Spotlight

Spotlight December

Lessons from the International Experience with Biosimilar Implementation

Biosimilars, an economical alternative to traditional biologic treatment, offer exciting opportunities to improve access to treatment (Elek et al. 2017) and cost savings as Canadian healthcare costs rise. However, despite these potential benefits, biosimilar uptake is lower than expected. Click here to read the full article.

Comments

Be the first to comment on this!

Note: Please enter a display name. Your email address will not be publically displayed